Educational recommendations on selected analytical and clinical aspects of natriuretic peptides with a focus on heart failure: A report from the IFCC committee on clinical applications of cardiac bio-markers

Peter A. Kavsak; Carolyn S.P. Lam; Amy K. Saenger; Allan S. Jaffe; Paul Collinson; Kari Pulkki; Tobjørn Omland; Guillaume Lefevre; Richard Body; Jordi Ordonez-Llanos; Fred S. Apple

doi:10.1373/clinchem.2019.306621

Educational recommendations on selected analytical and clinical aspects of natriuretic peptides with a focus on heart failure: A report from the IFCC committee on clinical applications of cardiac bio-markers

Peter A. Kavsak, Carolyn S.P. Lam, Amy K. Saenger, Allan S. Jaffe, Paul Collinson, Kari Pulkki, Tobjørn Omland, Guillaume Lefevre, Richard Body, Jordi Ordonez-Llanos, Fred S. Apple

University of Minnesota Twin Cities

Research output: Contribution to journal › Article › peer-review

19 Scopus citations

Original language	English (US)
Pages (from-to)	1221-1227
Number of pages	7
Journal	Clinical chemistry
Volume	65
Issue number	10
DOIs	https://doi.org/10.1373/clinchem.2019.306621
State	Published - Jan 1 2019

Bibliographical note

Funding Information:
Employment or Leadership: P.O. Collinson, The Journal of Applied Laboratory Medicine, AACC; F.S. Apple, Clinical Chemistry, AACC. Consultant or Advisory Role: P.A. Kavsak, Roche, Siemens, Beckman, Abbott; C. Lam, Boston Scientific, Bayer, Roche Diagnostics, AstraZeneca, Medtronic, Vifor Pharma, Novartis, Amgen, Merck, Janssen Research & Development LLC, Menarini, Boehringer Ingelheim, Novo Nordisk, Abbott Diagnostics, Corvia, Stealth BioTherapeutics, JanaCare, Biofourmis, Darma, Applied Therapeutics, WebMD Global LLC, Radcliffe Group Ltd and Corpus; A.S. Jaffe, Beckman-Coulter, Abbott, Siemens, Sphingotec, Brava, Novartis, Medscape; T. Omland, Abbott Diagnostics, Roche Diagnostics; R. Body, Siemens, LumiraDx; J. Ordonez-Llanos, Thermo Fischer; F.S. Apple, HyTest, LumiraDx, Siemens, Instrumentation Laboratory. Stock Ownership: None declared. Honoraria: P.A. Kavsak, Siemens, Beckman, Roche; T. Omland, Abbott Diagnostics, Roche Diagnostics, Siemens Healthcare; J. Ordonez-Llanos, Roche Diagnostics; F.S. Apple, Abbott Laboratories. Research Funding: T. Omland, funding from Abbott Diagnostics and Roche Diagnostics to institution; F.S. Apple, non-salary funding from Abbott, Abbott POC, Beckman Coulter, Siemens, Roche, Ortho Clinical Diagnostics, Qorvo, Becton Dickinson. Expert Testimony: None declared. Patents: P.A. Kavsak, an inventor on patents filed by McMaster University related to laboratory testing in acute cardiac care; specific to heart failure the following patent: US Patent # 8,491,871.

PubMed: MeSH publication types

Journal Article
Research Support, Non-U.S. Gov't

Access

10.1373/clinchem.2019.306621

OpenUrl availability

Full text

Cite this

Kavsak, P. A., Lam, C. S. P., Saenger, A. K., Jaffe, A. S., Collinson, P., Pulkki, K., Omland, T., Lefevre, G., Body, R., Ordonez-Llanos, J., & Apple, F. S. (2019). Educational recommendations on selected analytical and clinical aspects of natriuretic peptides with a focus on heart failure: A report from the IFCC committee on clinical applications of cardiac bio-markers. Clinical chemistry, 65(10), 1221-1227. https://doi.org/10.1373/clinchem.2019.306621

Educational recommendations on selected analytical and clinical aspects of natriuretic peptides with a focus on heart failure: A report from the IFCC committee on clinical applications of cardiac bio-markers. / Kavsak, Peter A.; Lam, Carolyn S.P.; Saenger, Amy K. et al.
In: Clinical chemistry, Vol. 65, No. 10, 01.01.2019, p. 1221-1227.

Research output: Contribution to journal › Article › peer-review

Kavsak, PA, Lam, CSP, Saenger, AK, Jaffe, AS, Collinson, P, Pulkki, K, Omland, T, Lefevre, G, Body, R, Ordonez-Llanos, J & Apple, FS 2019, 'Educational recommendations on selected analytical and clinical aspects of natriuretic peptides with a focus on heart failure: A report from the IFCC committee on clinical applications of cardiac bio-markers', Clinical chemistry, vol. 65, no. 10, pp. 1221-1227. https://doi.org/10.1373/clinchem.2019.306621

@article{2079d8ea43b04337b229109229be2ac0,

title = "Educational recommendations on selected analytical and clinical aspects of natriuretic peptides with a focus on heart failure: A report from the IFCC committee on clinical applications of cardiac bio-markers",

author = "Kavsak, {Peter A.} and Lam, {Carolyn S.P.} and Saenger, {Amy K.} and Jaffe, {Allan S.} and Paul Collinson and Kari Pulkki and Tobj{\o}rn Omland and Guillaume Lefevre and Richard Body and Jordi Ordonez-Llanos and Apple, {Fred S.}",

note = "Funding Information: Employment or Leadership: P.O. Collinson, The Journal of Applied Laboratory Medicine, AACC; F.S. Apple, Clinical Chemistry, AACC. Consultant or Advisory Role: P.A. Kavsak, Roche, Siemens, Beckman, Abbott; C. Lam, Boston Scientific, Bayer, Roche Diagnostics, AstraZeneca, Medtronic, Vifor Pharma, Novartis, Amgen, Merck, Janssen Research & Development LLC, Menarini, Boehringer Ingelheim, Novo Nordisk, Abbott Diagnostics, Corvia, Stealth BioTherapeutics, JanaCare, Biofourmis, Darma, Applied Therapeutics, WebMD Global LLC, Radcliffe Group Ltd and Corpus; A.S. Jaffe, Beckman-Coulter, Abbott, Siemens, Sphingotec, Brava, Novartis, Medscape; T. Omland, Abbott Diagnostics, Roche Diagnostics; R. Body, Siemens, LumiraDx; J. Ordonez-Llanos, Thermo Fischer; F.S. Apple, HyTest, LumiraDx, Siemens, Instrumentation Laboratory. Stock Ownership: None declared. Honoraria: P.A. Kavsak, Siemens, Beckman, Roche; T. Omland, Abbott Diagnostics, Roche Diagnostics, Siemens Healthcare; J. Ordonez-Llanos, Roche Diagnostics; F.S. Apple, Abbott Laboratories. Research Funding: T. Omland, funding from Abbott Diagnostics and Roche Diagnostics to institution; F.S. Apple, non-salary funding from Abbott, Abbott POC, Beckman Coulter, Siemens, Roche, Ortho Clinical Diagnostics, Qorvo, Becton Dickinson. Expert Testimony: None declared. Patents: P.A. Kavsak, an inventor on patents filed by McMaster University related to laboratory testing in acute cardiac care; specific to heart failure the following patent: US Patent # 8,491,871.",

year = "2019",

month = jan,

day = "1",

doi = "10.1373/clinchem.2019.306621",

language = "English (US)",

volume = "65",

pages = "1221--1227",

journal = "Clinical chemistry",

issn = "0009-9147",

publisher = "American Association for Clinical Chemistry Inc.",

number = "10",

}

TY - JOUR

T1 - Educational recommendations on selected analytical and clinical aspects of natriuretic peptides with a focus on heart failure

T2 - A report from the IFCC committee on clinical applications of cardiac bio-markers

AU - Kavsak, Peter A.

AU - Lam, Carolyn S.P.

AU - Saenger, Amy K.

AU - Jaffe, Allan S.

AU - Collinson, Paul

AU - Pulkki, Kari

AU - Omland, Tobjørn

AU - Lefevre, Guillaume

AU - Body, Richard

AU - Ordonez-Llanos, Jordi

AU - Apple, Fred S.

N1 - Funding Information: Employment or Leadership: P.O. Collinson, The Journal of Applied Laboratory Medicine, AACC; F.S. Apple, Clinical Chemistry, AACC. Consultant or Advisory Role: P.A. Kavsak, Roche, Siemens, Beckman, Abbott; C. Lam, Boston Scientific, Bayer, Roche Diagnostics, AstraZeneca, Medtronic, Vifor Pharma, Novartis, Amgen, Merck, Janssen Research & Development LLC, Menarini, Boehringer Ingelheim, Novo Nordisk, Abbott Diagnostics, Corvia, Stealth BioTherapeutics, JanaCare, Biofourmis, Darma, Applied Therapeutics, WebMD Global LLC, Radcliffe Group Ltd and Corpus; A.S. Jaffe, Beckman-Coulter, Abbott, Siemens, Sphingotec, Brava, Novartis, Medscape; T. Omland, Abbott Diagnostics, Roche Diagnostics; R. Body, Siemens, LumiraDx; J. Ordonez-Llanos, Thermo Fischer; F.S. Apple, HyTest, LumiraDx, Siemens, Instrumentation Laboratory. Stock Ownership: None declared. Honoraria: P.A. Kavsak, Siemens, Beckman, Roche; T. Omland, Abbott Diagnostics, Roche Diagnostics, Siemens Healthcare; J. Ordonez-Llanos, Roche Diagnostics; F.S. Apple, Abbott Laboratories. Research Funding: T. Omland, funding from Abbott Diagnostics and Roche Diagnostics to institution; F.S. Apple, non-salary funding from Abbott, Abbott POC, Beckman Coulter, Siemens, Roche, Ortho Clinical Diagnostics, Qorvo, Becton Dickinson. Expert Testimony: None declared. Patents: P.A. Kavsak, an inventor on patents filed by McMaster University related to laboratory testing in acute cardiac care; specific to heart failure the following patent: US Patent # 8,491,871.

PY - 2019/1/1

Y1 - 2019/1/1

UR - http://www.scopus.com/inward/record.url?scp=85072792010&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85072792010&partnerID=8YFLogxK

U2 - 10.1373/clinchem.2019.306621

DO - 10.1373/clinchem.2019.306621

M3 - Article

C2 - 31387884

AN - SCOPUS:85072792010

SN - 0009-9147

VL - 65

SP - 1221

EP - 1227

JO - Clinical chemistry

JF - Clinical chemistry

IS - 10

ER -

Educational recommendations on selected analytical and clinical aspects of natriuretic peptides with a focus on heart failure: A report from the IFCC committee on clinical applications of cardiac bio-markers

Bibliographical note

PubMed: MeSH publication types

Access

OpenUrl availability

Other files and links

Cite this